Safety and efficacy of first-line dacomitinib in Japanese patients with advanced non-small cell lung cancer.
Nishio M, Kato T, Niho S, Yamamoto N, Takahashi T, Nogami N, Kaneda H, Fujita Y, Wilner K, Yoshida M, Isozaki M, Wada S, Tsuji F, Nakagawa K.
Nishio M, et al. Among authors: tsuji f.
Cancer Sci. 2020 May;111(5):1724-1738. doi: 10.1111/cas.14384. Epub 2020 Apr 14.
Cancer Sci. 2020.
PMID: 32159882
Free PMC article.
Clinical Trial.